These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38933871)

  • 1. Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer.
    Jin Y; Lu X; Liu Y; Su L; Bao C; Guo H
    Cytotechnology; 2024 Aug; 76(4):465-482. PubMed ID: 38933871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.
    Fang Y; Wang L; Wan C; Sun Y; Van der Jeught K; Zhou Z; Dong T; So KM; Yu T; Li Y; Eyvani H; Colter AB; Dong E; Cao S; Wang J; Schneider BP; Sandusky GE; Liu Y; Zhang C; Lu X; Zhang X
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32990678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
    Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
    J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer.
    Zhan L; Zhang J; Wei B; Cao Y
    Autophagy; 2022 Apr; 18(4):942-943. PubMed ID: 35174769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen processing and immune regulation in the response to tumours.
    Reeves E; James E
    Immunology; 2017 Jan; 150(1):16-24. PubMed ID: 27658710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
    Zhan L; Zhang J; Zhang J; Liu X; Zhu S; Shi Y; He Y; Wang W; Fan Y; Tang Z; Chen G; Wei B; Cao Y
    Cancer Lett; 2022 Mar; 529():37-52. PubMed ID: 34974132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation.
    Dersh D; Yewdell JW
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
    Deng P; Wang Z; Chen J; Liu S; Yao X; Liu S; Liu L; Yu Z; Huang Y; Xiong Z; Xiao R; Gao J; Liang W; Chen J; Liu H; Hong JH; Chan JY; Guan P; Chen J; Wang Y; Yin J; Li J; Zheng M; Zhang C; Zhou P; Kang T; Teh BT; Yu Q; Zuo Z; Jiang Q; Liu J; Xiong Y; Xia X; Tan J
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36201246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct antigen presentation is the canonical pathway of cytomegalovirus CD8 T-cell priming regulated by balanced immune evasion ensuring a strong antiviral response.
    Büttner JK; Becker S; Fink A; Brinkmann MM; Holtappels R; Reddehase MJ; Lemmermann NA
    Front Immunol; 2023; 14():1272166. PubMed ID: 38149242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.
    Demel UM; Böger M; Yousefian S; Grunert C; Zhang L; Hotz PW; Gottschlich A; Köse H; Isaakidis K; Vonficht D; Grünschläger F; Rohleder E; Wagner K; Dönig J; Igl V; Brzezicha B; Baumgartner F; Habringer S; Löber J; Chapuy B; Weidinger C; Kobold S; Haas S; Busse AB; Müller S; Wirth M; Schick M; Keller U
    J Clin Invest; 2022 May; 132(9):. PubMed ID: 35499080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
    Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPS6 promotes tumor progression and reduces CD8
    Du WQ; Zhu ZM; Jiang X; Kang MJ; Pei DS
    Acta Pharmacol Sin; 2023 Sep; 44(9):1890-1905. PubMed ID: 37095198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
    Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
    Front Immunol; 2019; 10():1505. PubMed ID: 31333652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.
    Shukla A; Cloutier M; Appiya Santharam M; Ramanathan S; Ilangumaran S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
    Dhatchinamoorthy K; Colbert JD; Rock KL
    Front Immunol; 2021; 12():636568. PubMed ID: 33767702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
    Lin CY; Tsai CL; Chao A; Lee LY; Chen WC; Tang YH; Chao AS; Lai CH
    J Mol Med (Berl); 2021 Aug; 99(8):1125-1137. PubMed ID: 33954835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cytomegalovirus immune evasion identifies direct antigen presentation as the predominant mode of CD8 T-cell priming during immune reconstitution after hematopoietic cell transplantation.
    Holtappels R; Büttner JK; Freitag K; Reddehase MJ; Lemmermann NA
    Front Immunol; 2024; 15():1355153. PubMed ID: 38426094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance.
    Balasubramanian A; John T; Asselin-Labat ML
    Biochem Soc Trans; 2022 Apr; 50(2):825-837. PubMed ID: 35343573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.